Dr. Renuka Iyer Appointed Chief Medical Officer of NCCN, Leading Cancer Care Innovations

Renuka Iyer, MD, Appointed Chief Medical Officer of NCCN

The National Comprehensive Cancer Network (NCCN), a prominent alliance of leading cancer centers, has recently announced the appointment of Dr. Renuka Iyer as its Chief Medical Officer (CMO), effective February 26, 2026. Recognized for her significant contributions to oncology, Dr. Iyer brings a wealth of expertise and leadership to NCCN, known for its commitment to advancing quality cancer care.

A Distinguished Career in Oncology

Dr. Renuka Iyer's career is rooted in a profound dedication to oncology, currently serving as a Professor of Oncology at the Roswell Park Comprehensive Cancer Center, a key member institution of NCCN. Additionally, she holds several key positions at Roswell Park, including Section Chief of Gastrointestinal Oncology and Vice Chair of Faculty Affairs. Her academic credentials are bolstered by her role at Jacobs School of Medicine at the University of Buffalo, where she is also a Professor of Medicine.

Having completed her fellowship in medical oncology at Roswell Park, Dr. Iyer's medical education began at Grant Medical College in Mumbai. She further honed her expertise with a residency at Cornell University School of Medicine. Dr. Iyer is board certified in both internal medicine and oncology, a recognition of her extensive knowledge and skill in the domain.

Contributions to Cancer Care and Research

Throughout her career, Dr. Iyer has been a powerful advocate for advancing research and improving clinical care. She has published extensively in the field, contributing numerous peer-reviewed articles, abstracts, and book chapters. Her research interests are particularly focused on rare cancers, immunotherapy, and quality of life for cancer patients. She has received accolades from several organizations, including the American Cancer Society and the North American Neuroendocrine Tumor Society, underscoring her impact in the field of oncology.

Crystal S. Denlinger, MD, CEO of NCCN, expressed enthusiasm about Dr. Iyer's leadership, stating, "Renuka is the perfect person to take on such an important role impacting treatment and outcomes for people with cancer around the world. Her commitment to advancing research and enhancing patient care is truly impressive." With Dr. Iyer at the helm, NCCN focuses on enhancing access to evidence-based treatment, ultimately aiming to improve the lives of cancer patients globally.

Role as Chief Medical Officer

As the new CMO, Dr. Iyer will oversee the NCCN Guidelines program, which includes nearly 90 guidelines addressing various types of cancer management, prevention, and supportive care. Each guideline undergoes regular reviews and updates, ensuring that they reflect the latest evidence-based practices. The guidelines are not only critical for healthcare providers but also serve as an invaluable resource for patients and caregivers seeking quality cancer care.

Dr. Iyer will also manage NCCN's Continuing Education department and contribute to the JNCCN—Journal of the National Comprehensive Cancer Network. Her commitment to education and collaboration resonates with the NCCN mission to elevate the standards of cancer treatment and research.

A Vision for the Future

In her own words, Dr. Iyer expressed her enthusiasm for her new role, stating, "I am honored to be chosen for this prestigious position and excited to be at NCCN during a time when there are so many updates and opportunities to innovate how we deliver information to help our patients." Dr. Iyer’s vision and leadership will be instrumental in navigating the complexities of cancer care and solidifying NCCN's reputation as a leader in the oncology field.

With her vast experience and commitment to innovation, Dr. Renuka Iyer is poised to make a lasting impact on cancer care not only at NCCN but across the globe, ensuring that patients receive the best possible treatment and support. As her tenure begins, the cancer community looks forward to the advancements and improvements she brings to the field.